Assignee
''NEXTGEN'' COMPANY LTD
RU·6 granted patents·1 pending application·0 citations·filing 2012–2017
Top patents by PatentIndex Score
7 records- 0144US10040837B2Nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression“NEXTGEN” COMPANY LTD·Filed 2017·Granted Aug 7, 2018·0 cites·9 claims
- 0241US9730959B2Biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, a method of making the biocomposite and a method of treating injuries“NEXTGEN” COMPANY LTD·Filed 2012·Granted Aug 15, 2017·0 cites·17 claims
- 0337US10434145B2Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans“NEXTGEN” COMPANY LTD·Filed 2017·Granted Oct 8, 2019·0 cites·9 claims
- 0436US9896493B2Nucleotide sequence and pharmaceutical composition based thereon with prolonged VEGF transgene expression“NEXTGEN” COMPANY LTD·Filed 2016·Granted Feb 20, 2018·0 cites·12 claims
- 0533US11406739B2Method for creating a personalized gene-activated implant for regenerating bone tissue“NEXTGEN” COMPANY LTD·Filed 2017·Granted Aug 9, 2022·0 cites·19 claims
- 0632US9616103B2Pharmaceutical composition for stimulation of angiogenesis“NEXTGEN” COMPANY LTD·Filed 2013·Granted Apr 11, 2017·0 cites·19 claims
- 0730US2017189488A1Codon-optimized recombinant plasmid, method of stimulating peripheral nerve regeneration, and method of treating nerve damage in humans''NEXTGEN'' COMPANY LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ''NEXTGEN'' COMPANY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →